Analyst Reco. Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Delayed Nyse Other stock markets 01:00:01 2024-07-03 pm EDT			5-day change	1st Jan Change
0.3755 ^USD	+8.37%		+32.26%	-77.78%

Jun. 28	Microba Life Sciences Completes Screening for Autoimmune Disease Program; Shares Down 3%	MT
May. 30	Transcript : Ginkgo Bioworks Holdings, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing	May. 16	MT
BTIG Downgrades Ginkgo Bioworks Holdings to Sell From Neutral, Price Target is $0.50	May. 15	MT
Morgan Stanley Trims Ginkgo Bioworks Price Target to $1 From $2, Maintains Equal Weight Rating	May. 15	MT
Ginkgo Bioworks Holdings Insider Bought Shares Worth $271,815, According to a Recent SEC Filing	May. 14	MT
Ginkgo Bioworks Holdings Insider Sold Shares Worth $1,606,162, According to a Recent SEC Filing	May. 14	MT
William Blair Downgrades Ginkgo Bioworks Holdings to Underperform From Market Perform	May. 10	MT
TD Cowen Cuts Price Target on Ginkgo Bioworks to $3 From $7, Maintains Outperform Rating	Mar. 01	MT
Goldman Sachs Trims Ginkgo Bioworks Price Target to $1.10 From $1.25, Maintains Sell Rating	Jan. 22	MT
Raymond James Downgrades Ginkgo Bioworks to Market Perform From Outperform, Price Target is $2.50	Nov. 14	MT
BTIG Downgrades Ginkgo Bioworks Holdings to Neutral From Buy	Nov. 09	MT
Goldman Sachs Downgrades Ginkgo Bioworks to Sell From Neutral, Adjusts Price Target to $1.25 From $3	23-06-02	MT
William Blair Downgrades Ginkgo Bioworks Holdings to Market Perform From Outperform	23-05-11	MT
Berenberg Bank Initiates Coverage on Ginkgo Bioworks With Buy Rating, $4 Price Target	22-11-29	MT
Morgan Stanley Starts Ginkgo Bioworks Holdings at Equalweight With $5 Price Target	22-10-04	MT
BTIG Adjusts Price Target on Ginkgo Bioworks Holdings to $6 From $5, Reiterates Buy Rating	22-08-16	MT
Raymond James Adjusts Price Target on Ginkgo Bioworks Holdings to $14.50 From $11.50, Keeps Outperform Rating	22-08-16	MT
Jefferies Adjusts Price Target on Ginkgo Bioworks Holdings to $4.35 From $11.50, Reiterates Buy Rating	22-06-16	MT
BofA Securities Downgrades Ginkgo Bioworks Holdings to Underperform From Neutral, Adjusts Price Target to $3 From $6	22-05-18	MT
Cowen Initiates Ginkgo Bioworks Holdings at Outperform With $12 Price Target	22-03-02	MT
Goldman Sachs Starts Ginkgo Bioworks Holdings at Neutral With $7 Price Target	22-02-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Analyst Reco.

Filters